Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Einstein-Extension: rivaroxaban for long-term prevention of recurrent venous thromboembolism
2006-004494-96Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) comparing Rivaroxaban once daily with Placebo (2 arms). Started Dec 2006; status: completed.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on 2006-004494-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004494-96.